InterCure Acquires ISHI In $4.92M Share Deal For US Cannabis Expansion

InterCure Ltd. has announced the acquisition of Botanico Ltd., known as ISHI, to enhance its global cannabis portfolio and gain entry into premium American cultivation technology and brand partnerships. The acquisition provides InterCure access to ISHI’s advanced AI-driven cultivation technologies, automated production systems, and exclusive partnerships with leading U.S. cannabis companies such as The Flowery, which has a strong retail presence in Florida and New York. The deal is structured in two phases: initially acquiring 50% of ISHI’s equity through 2.47 million InterCure shares, with the remaining 50% to be acquired upon ISHI achieving sustained profitability or within two years, totaling approximately 10% of InterCure’s outstanding shares. ISHI’s co-founders will join InterCure’s leadership team, and all employee stock options at ISHI will convert to InterCure options, ensuring operational integration. This acquisition positions InterCure to broaden its international reach while maintaining pharmaceutical-grade standards amid evolving global medical cannabis market regulations. The transaction is expected to close in the first quarter of 2026, pending regulatory approvals.